Halberd Corporation (HALB) は上場企業です ヘルスケア セクターの バイオテクノロジー 業界で事業展開. 本社所在地は Jackson Center, PA, アメリカ. 現CEOは William A. Hartman.
HALB を有する IPO日 2012-09-25, に上場 Other OTC, 時価総額 $484.92K.
Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.
